Viking Therapeutics, Inc. - Common Stock - Bilanço (NASDAQ:VKTX) | MetaTrader

Tam grafiği aç Full chart

Financials

Genel Bakış Tablolar İstatistikler

Çeyreklik Yıllık

Toplam varlıklar 256.5 M210.66 M168.53 M368.49 M908.32 M715.73 M Toplam yükümlülükler 12.16 M8.78 M23.21 M20.07 M28.04 M76.67 M Toplam özsermaye 244.34 M201.88 M145.32 M348.42 M880.28 M639.06 M Toplam yükümlülükler ve hissedarların özsermayesi 256.5 M210.66 M168.53 M368.49 M908.32 M715.73 M Toplam borç —————— Net borç ——————

Haberler

Why Is Viking Therapeutics (VKTX) Up 3.2% Since Last Earnings Report?

LLY Stock Gains 4% to All-Time High: Is Obesity Access the Catalyst?

Viking Therapeutics, Inc. (VKTX) Exceeds Market Returns: Some Facts to Consider

Lake Street, Viking Therapeutic hissesine al önerisiyle başladı

Truist, Viking Therapeutic hissesi için al önerisi verdi

Can EU Label Expansions of NVO's GLP-1 Drugs Spur Sales Growth?

LLY Reports Third Phase III Win for Next-Generation Obesity Drug

Can Mounjaro, Zepbound & Foundayo Keep Fueling LLY's Growth Story?

This Hot Weight-Loss Drug Stock May Have a Surprise Challenger

Can Novo Nordisk Sustain Its GLP-1 Edge Amid Lilly's Growing Pressure?

Lilly Bets on Next-Generation Obesity Drugs to Stay Ahead

Viking oral kilo kaybı ilacı VK2735 için faz 2 verilerini sundu